Please assess the completion status of the following clinical trial:

Trial Title: Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Current male or female cigarette smokers who are motivated to stop smoking.~* Smoked an average of 10 cigarettes per day during past year and the month prior to first visit.~Exclusion Criteria:~* Patients who have used a nicotine replacement product, bupropion, clonidine or notriptyline within the past 6 months.~* Patients currently with depression or diagnosed with depression in past 12 months.~* Past or present history of psychosis, panic disorder, or bipolar disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- varenicline (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).